JPH0525192A - Beta-d-glucose - Google Patents

Beta-d-glucose

Info

Publication number
JPH0525192A
JPH0525192A JP32841391A JP32841391A JPH0525192A JP H0525192 A JPH0525192 A JP H0525192A JP 32841391 A JP32841391 A JP 32841391A JP 32841391 A JP32841391 A JP 32841391A JP H0525192 A JPH0525192 A JP H0525192A
Authority
JP
Japan
Prior art keywords
compound
beta
ethylidene
glucopyranose
etoposide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP32841391A
Other languages
Japanese (ja)
Other versions
JPH0575759B2 (en
Inventor
Tadashi Fujii
正 藤井
Yukio Tsukui
幸雄 筑井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Priority to JP32841391A priority Critical patent/JPH0525192A/en
Publication of JPH0525192A publication Critical patent/JPH0525192A/en
Publication of JPH0575759B2 publication Critical patent/JPH0575759B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

PURPOSE:To provide a novel beta-D-glucose having an antitumor activity, useful as an intermediate for synthesizing a carcinostatic agent: etoposide, and giving the easily purified etoposide in a high purity and a good yield. CONSTITUTION:beta-D-Glucose of formula I [R1 is COCHX2. COCX3 (X is halogen)@{947/28}, e.g. 4,6-O-ethylidene-1-O-benzyloxycarbonyl-2,3-di-O- dichloroacetyl-beta-D-glucopyranose. The compound of formula I is produced, e.g. by reacting 4,6-O-ethylidene-1-O-benzyloxycarbonyl-beta-D-glucopyranose with dihalogeno or trihalogenoacetyl chloride, etc., in an inert solvent such as dichloroethane and subsequently hydrogenatingly demasking the produced compound of formula III in the presence of palladium black, etc., in a solvent.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はエトポシド用の中間体と
して有用な下記式(6)で示されるβ−D−グルコ−ス
に関する。エトポシドは抗腫瘍活性を示し、制癌剤とし
て有用な物質である。
TECHNICAL FIELD The present invention relates to β-D-glucose represented by the following formula (6) which is useful as an intermediate for etoposide. Etoposide exhibits antitumor activity and is a useful substance as a carcinostatic agent.

【従来の技術】化合物(1)の製造法としては次の工程
によるものが既に知られている。(特公昭46−378
37号公報参照)
2. Description of the Related Art As a method for producing the compound (1), the following steps are already known. (Japanese Patent Publication No. 46-378
(See Japanese Patent No. 37)

【0002】[0002]

【化2】 [Chemical 2]

【0003】(式中Aはホルミル又はアセチル、Bはベ
ンジルオキシカルボニルを示す)
(In the formula, A represents formyl or acetyl, and B represents benzyloxycarbonyl.)

【発明が解決しようとする課題】しかし、上記の方法
は、Aを除去した後、Bを除去するという2工程を必要
とし、しかもAの除去による長時間(例えば20〜30
時間反応させても完結しない)を必要とし、又、着色物
などの副生物が増加するため得られるエトポシドの品質
が悪く、収率も低いという欠点がある。
However, the above-mentioned method requires two steps of removing A and then B, and the removal of A takes a long time (for example, 20 to 30).
However, the quality of the obtained etoposide is poor and the yield is low.

【課題を解決するための手段】そこで本発明者らはエト
ポシドの新規製法につき種々検討した結果、ジ又はトリ
ハロゲノアセチルハロゲン化物を利用して得られる式
(3)
The inventors of the present invention have made various investigations on new methods for producing etoposide, and as a result, formula (3) obtained by using di- or trihalogenoacetyl halides has been investigated.

【0004】[0004]

【化3】 [Chemical 3]

【0005】〔式中R1 及びR2 は同じか異なって式−
COCHX2 又は−COCX3 (式中Xはハロゲン原子
を示す。)を示す。〕で表わされる化合物にアルコ−ル
類、アミン類及び/又はアンモニアを反応させるとR1
とR2 が一挙に除去されてエトポシドが得られること、
得られたエトポシドは不純物が少なく、精製も容易であ
ることが判明し、式(6)
[Wherein R 1 and R 2 are the same or different and are represented by the formula-
COCHX 2 or —COCX 3 (wherein X represents a halogen atom) is shown. ] When a compound represented by the following formula is reacted with alcohols, amines and / or ammonia, R 1
And R 2 are removed at once to obtain etoposide,
The obtained etoposide was found to have few impurities and to be easily purified.

【0006】[0006]

【化4】 [Chemical 4]

【0007】〔式中、R1 は−COCHX2 又は−CO
CX3 (Xはハロゲン原子を示す。)を示す。〕で表わ
されるβ−D−グルコ−スがエトポシド用中間体として
有用であることを見い出した。上記式(6)において、
1 におけるXとしては例えばフッ素、塩素、臭素、ヨ
ウ素などがあげられるが、塩素又は臭素が実用的に好ま
しい。R1 としては例えばジフルオロアセチル、ジクロ
ロアセチル、ジブロモアセチル、ジヨウドアセチル、ト
リフルオロアセチル、トリクロロアセチル、トリブロモ
アセチル、トリヨ−ドアセチルなどがあげられる。
[Wherein R 1 is --COCHX 2 or --CO
CX 3 (X represents a halogen atom) is shown. ] The β-D-glucose represented by the formula] was found to be useful as an intermediate for etoposide. In the above formula (6),
Examples of X in R 1 include fluorine, chlorine, bromine, iodine and the like, but chlorine or bromine is practically preferable. Examples of R 1 include difluoroacetyl, dichloroacetyl, dibromoacetyl, diiodoacetyl, trifluoroacetyl, trichloroacetyl, tribromoacetyl, triiodoacetyl and the like.

【0008】ここで化合物(6)は新規化合物であり、
公知の4,6−O−エチリデン−1−O−ベンジルオキ
シカルボニル−β−D−グルコピラノ−ス(7)を原料
として、例えば次の反応経路を経て合成される。
The compound (6) is a novel compound,
For example, the known 4,6-O-ethylidene-1-O-benzyloxycarbonyl-β-D-glucopyranose (7) is used as a starting material and is synthesized through the following reaction route.

【0009】[0009]

【化5】 [Chemical 5]

【0010】(式中R1 は前記に同じである。)即ち、
4,6−O−エチリデン−1−O−ペンジルオキシカル
ボニル−β−D−グルコピラノ−ス(7)を不活性溶媒
中、ジハロゲノ又はトリハロゲノアセチルクロライドを
反応させて得られる4,6−O−エチリデン−1−O−
ベンジルオキシカルボニル−2,3−ジ−O−ハロゲノ
アセチル−β−D−グルコピラノ−ス、(8)を水素化
分解することにより、化合物(6)を得ることができ
る。なお、水素化分解に際し若干のα−体の生成は避け
られないが、化合物(6)は反応液からβ−体のみが選
択的に結晶化してくるので、α−体とβ−体の分離が容
易であるという性質を有する。又、化合物(6)のβ−
体は安定性が良好でα−体への異性化がほとんどみられ
ないので、長期間の保存が可能である。
(In the formula, R 1 is the same as above.)
4,6-O-ethylidene-1-O-pentyloxycarbonyl-β-D-glucopyranoose (7) obtained by reacting dihalogeno or trihalogenoacetyl chloride in an inert solvent -Ethylidene-1-O-
Compound (6) can be obtained by hydrogenolysis of benzyloxycarbonyl-2,3-di-O-halogenoacetyl-β-D-glucopyranose (8). Although a small amount of α-form is inevitable during the hydrogenolysis, only β-form of compound (6) crystallizes selectively from the reaction solution, and therefore α-form and β-form are separated. Has the property that it is easy. In addition, β- of compound (6)
Since the body has good stability and almost no isomerization to the α-form is observed, it can be stored for a long period of time.

【0011】[0011]

【実施例】【Example】

実施例1 (a)4,6−O−エチリデン−1−O−ベンジルオキ
シカルボニル−2,3−ジ−O−ジクロロアセチル−β
−D−グルコピラノ−ス(8)(R1 =COCHC
2 ) 4,6−O−エチリデン−1−O−ベンジルオキシカル
ボニル−β−D−グルコピラノ−ス(7)34.0gを
1,2−ジクロロエタン340mlに懸濁し、ピリジン
23.7gを加えた後0〜5℃に冷却する。これにジク
ロロアセチルクロライド32.4gを約1時間かけて滴
下した後,更に0.5時間攪拌を続ける。ついで反応液
を水洗し有機層を無水硫酸マグネシウムで乾燥した後減
圧濃縮して化合物(8)(R1 =COCHCl2 )5
1.0gを得た(収率90.7%)。 m.p.150〜151℃ IR νmax (KBr) 1770, 1255, 1100, 820cm -1 (b)4,6−O−エチリデン−2,3−ジ−O−ジク
ロロアセチル−β−D−グルコピラノ−ス(6)(R1
=COCHCl2 ) 化合物(8)(R1 =−COCHCl2 )10.0gを
アセトン50mlに溶解し、パラジウム黒1.0gを加
えて−5〜10℃で加圧下に水素化分解を行う。反応終
了後触媒をろ別し、溶媒を減圧下に留去する。残渣にジ
イソプロピルエ−テル17mlを加えて0℃迄冷却後吸
引ろ過して化合物(6)(R1 =−COCHCl2
7.3gを得た(収率95.9%)。 m.p.133〜135℃ IR νmax (KBr) 3445, 1775, 1305, 1165, 1095, 10
05, 815cm -1
 Example 1 (a) 4,6-O-ethylidene-1-O-benzyloxy
Cycarbonyl-2,3-di-O-dichloroacetyl-β
-D-glucopyranose (8) (R1= COCHC
l2) 4,6-O-Ethylidene-1-O-benzyloxycal
34.0 g of bonyl-β-D-glucopyranose (7)
Suspended in 340 ml of 1,2-dichloroethane, pyridine
After adding 23.7 g, cool to 0-5 ° C. Jiku
Add 32.4 g of loroacetyl chloride over about 1 hour.
After dropping, the stirring is continued for another 0.5 hour. Then the reaction liquid
Washed with water, dried the organic layer over anhydrous magnesium sulfate, and then reduced.
Compound (8) (R1= COCHCl2) 5
1.0 g was obtained (yield 90.7%). m. p. 150-151 ° C IR νmax(KBr) 1770, 1255, 1100, 820cm-1  (B) 4,6-O-ethylidene-2,3-di-O-dicu
Loloacetyl-β-D-glucopyranose (6) (R1
= COCHCl2) Compound (8) (R1= -COCHCl2) 10.0 g
Dissolve in 50 ml of acetone and add 1.0 g of palladium black.
Then, hydrogenolysis is performed under pressure at -5 to 10 ° C. End of reaction
After completion, the catalyst is filtered off and the solvent is distilled off under reduced pressure. Di residue
Add 17 ml of isopropyl ether, cool to 0 ° C, and suck.
Compound (6) (R1= -COCHCl2)
7.3 g was obtained (yield 95.9%). m. p. 133-135 ° C IR νmax(KBr) 3445, 1775, 1305, 1165, 1095, 10
05, 815cm-1

【0012】実施例2 (a)4,6−O−エチリデン−1−O−ベンジルオキ
シカルボニル−2,3−ジ−O−ジブロモアセチル−β
−D−グルコピラノ−ス(8)(R2 =COCHB
2 ) 4,6−O−エチリデン−1−O−ベンジルオキシカル
ボニル−β−D−グルコピラノ−ス(7)5.1gを
1,2−ジクロロエタン51mlに懸濁しピリジン3.
6gを加えた後0〜5℃に冷却する。これにジブロモア
セチルクロライド7.8gを約1時間かけて滴下した後
更に30分間攪拌を続ける。ついで、反応液を水洗し、
有機層を無水硫酸マグネシウムで乾燥した後25mlに
なるまで減圧濃縮することにより化合物(8)((R1
=COCHBr2 )の1.2−ジクロロエタン溶液を得
た。 (b)4,6−O−エチリデン−2,3−ジ−O−ジプ
ロモアセチル−β−D−グルコピラノ−ス(6)(R1
=−COCHBr2 ) (a)の化合物(8)(R1 =−COCHBr2 )の
1,2−ジクロロエタン溶液25mlにパラジウム黒
0.4gを加えて−10〜−5℃で加圧下に水素添加を
行う。反応終了後触媒をろ別し化合物(6)(R1=−
COCHBr2 )の1,2−ジクロロエタン溶液を得
た。
Example 2 (a) 4,6-O-ethylidene-1-O-benzyloxycarbonyl-2,3-di-O-dibromoacetyl-β
-D- glucopyranose - scan (8) (R 2 = COCHB
r 2 ) 4,6-O-ethylidene-1-O-benzyloxycarbonyl-β-D-glucopyranose (7) (5.1 g) was suspended in 51 ml of 1,2-dichloroethane to prepare pyridine.
After adding 6 g, cool to 0-5 ° C. 7.8 g of dibromoacetyl chloride was added dropwise thereto over about 1 hour, and stirring was continued for another 30 minutes. Then, wash the reaction solution with water,
The organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure to 25 ml to give compound (8) ((R 1
= COCHBr 2) of 1.2 to obtain a dichloroethane solution. (B) 4,6-O-ethylidene-2,3-di-O-dipromoacetyl-β-D-glucopyranose (6) (R 1
= -COCHBr 2) Compound (8) (R 1 = -COCHBr 2) 1,2-dichloroethane solution 25ml to hydrogenation at -10 to-5 ° C. by the addition of palladium black 0.4g under pressure of (a) I do. After completion of the reaction, the catalyst was filtered off and the compound (6) (R 1 =-
A 1,2-dichloroethane solution of COCHBr 2 ) was obtained.

【0013】実施例3 (a)4,6−O−エチリデン−1−O−ベンジルオキ
シカルボニル−2,3−ジ−O−トリクロロアセチル−
β−D−グルコピラノ−ス(8)(R1 =−COCCl
3 ) 実施例2(a)においてジブロモアセチルクロライドの
代りにトリクロロアセチルクロライド3.5gを用いて
化合物(8)(R1 =COCCl3 )の1,2−ジクロ
ロエタン溶液25mlを得た。 (b)4,6−O−エチリデン−2,3−O−トリクロ
ロアセチル−β−D−グルコピラノ−ス(6)(R1
−COCCl3 ) (a)で得れた溶液25mlを用い、実施例2(6)と
同様にして化合物(6)(R1 =−COCCl3 )の
1,2−ジクロロエタン溶液25mlを得た。
Example 3 (a) 4,6-O-ethylidene-1-O-benzyloxycarbonyl-2,3-di-O-trichloroacetyl-
β-D-glucopyranose (8) (R 1 = -COCCl
3 ) Using 2.5 g of trichloroacetyl chloride instead of dibromoacetyl chloride in Example 2 (a), 25 ml of a 1,2-dichloroethane solution of compound (8) (R 1 = COCCl 3 ) was obtained. (B) 4,6-O-ethylidene-2,3-O-trichloroacetyl-β-D-glucopyranose (6) (R 1 =
-COCCl 3) using the resulting solution 25ml in (a), to obtain a 1,2-dichloroethane solution 25ml of compound in the same manner as in Example 2 (6) (6) ( R 1 = -COCCl 3).

【0014】参考例 (a)4′−ジクロロアセチル−4′−デメチル−エピ
ポドフィロトキシン(5)(R2 =COCHCl2 ) 4′−デメチル−エピポドフィロトキシン(4)8gを
アセトン160mlに溶解し、ピリジン3.2gを加え
た後−5〜−10℃に冷却する。これにジクロロアセチ
ルクロライド4.1gを約1.5時間かけて滴下し、更
に0.5時間攪拌する。ついで、減圧下にアセトンを留
去し、得られた固体を1,2−ジクロロエタン160m
lに溶解した後水洗する。次いでこの1,2−ジクロロ
エタン溶液を無水硫酸マグネシウムで乾燥後減圧下に濃
縮して化合物(5)(R2 =−COCHCl2 )9.5
gを得た(収率93.4%)。 m.p.207〜208℃ IR νmax (KBr) 3540, 1775, 1600, 1485, 1235, 1
130cm -1 (b)4′−ジクロロアセチル−4′−デメチル−エピ
ポドフィロトキシン−β−D−2,3−ジ−O−ジクロ
ロアセチル−4,6−O−エチリデングルコシド(3)
(R1,R2 =−COCHCl2 ) 化合物(5)(R2 =−COCHCl2 )3.0gを
1,2−ジクロロエタン60mlに溶解し、ついで化合
物(6)(R1 =−COCHCl2 )2.5gを加えて
−10℃に冷却する。三フッ化ホウ素エチルエ−テラ−
ト1.1gを約1.5時間かけて滴下し、終了後更に
0.5時間攪拌を続ける。ピリジン0.8gを内温−5
〜−10℃に保ちながら滴下した後水を加えて洗浄す
る。有機層を無水硫酸マグネシウムで乾燥後、減圧下に
濃縮し、残渣をメタノ−ルから再結晶して化合物(3)
(R1,R2 =−COCHCl2 )4.4gを得た(収率
81.4%)。 m.p.207〜208℃ (c)4′−ジクロロアセチル−4′−デメチル−エピ
ポドフィロトキシン−β−D−2,3−ジ−O−ジクロ
ロアセチル−4,6−O−エチリデングルコシド(3)
(R1,R2 =−COCHCl2 )1g及び酢酸アンモニ
ウム1gをメタノ−ル20mlに溶解し、室温で1.5
時間攪拌する。反応終了後メタノ−ルを10mlまで濃
縮し、冷却することによりエトポシドの結晶0.55g
を得た(収率86.1%)。 ここで得た結晶のTLCのRf値(シリカゲル、展開溶
媒クロロホルム:メタノ−ル=9:1)、IR,NMR
及び旋光度は特公昭46−37837号の方法により得
られた物質のそれ同一であった。 m.p.259〜260℃,Rf=0.44
Reference Example (a) 4'-Dichloroacetyl-4'-demethyl-epi
Podophyllotoxin (5) (R2= COCHCl2) 4'-demethyl-epipodophyllotoxin (4) 8 g
Dissolve in 160 ml of acetone and add 3.2 g of pyridine.
After that, it is cooled to -5 to -10 ° C. Dichloro acetyl
4.1 g of luchloride was added dropwise over about 1.5 hours, and
Stir for 0.5 hours. Then, distill off acetone under reduced pressure.
The solid obtained was removed and 1,2-dichloroethane (160 m)
It is dissolved in 1 and washed with water. Then this 1,2-dichloro
The ethane solution was dried over anhydrous magnesium sulfate and concentrated under reduced pressure.
Compound (5) (R2= -COCHCl2) 9.5
g was obtained (yield 93.4%). m. p. 207-208 ° C IR νmax(KBr) 3540, 1775, 1600, 1485, 1235, 1
130 cm-1  (B) 4'-dichloroacetyl-4'-demethyl-epi
Podophyllotoxin-β-D-2,3-di-O-diclo
Roacetyl-4,6-O-ethylidene glucoside (3)
(R1, R2= -COCHCl2) Compound (5) (R2= -COCHCl2) 3.0 g
Dissolve in 60 ml of 1,2-dichloroethane, then combine
Thing (6) (R1= -COCHCl2) Add 2.5g
Cool to -10 ° C. Boron trifluoride ethyl ether
1.1g was added dropwise over about 1.5 hours, and after the completion,
Continue stirring for 0.5 hour. Pyridine 0.8g inside temperature -5
While maintaining at -10 ℃, add water and wash.
It After drying the organic layer over anhydrous magnesium sulfate,
Concentrate and recrystallize the residue from methanol to give compound (3)
(R1, R2= -COCHCl2) 4.4 g were obtained (yield
81.4%). m. p. 207-208 ° C (c) 4'-dichloroacetyl-4'-demethyl-epi
Podophyllotoxin-β-D-2,3-di-O-diclo
Roacetyl-4,6-O-ethylidene glucoside (3)
(R1, R2= -COCHCl2) 1 g and ammonium acetate
1 g of um was dissolved in 20 ml of methanol, and 1.5 was dissolved at room temperature.
Stir for hours. After completion of the reaction, concentrate methanol to 10 ml.
0.55 g of crystals of etoposide after shrinking and cooling
Was obtained (yield 86.1%). Rf value of TLC of the crystals obtained here (silica gel, developed solution)
Medium chloroform: methanol = 9: 1), IR, NMR
And the optical rotation are obtained by the method of Japanese Examined Patent Publication No. 46-37837.
It was identical to that of the substance given. m. p. 259 to 260 ° C., Rf = 0.44

【0015】[0015]

【効果】上記参考例から明らかなように本発明のβ−D
−グルコ−スを用いることにより少ない工程数でエトポ
シドが高純度で収率よく得ることができる。
[Effect] As is apparent from the above reference example, β-D of the present invention
-By using glucose, etoposide can be obtained with high purity and high yield in a small number of steps.

Claims (1)

【特許請求の範囲】 【請求項1】式 【化1】 〔式中、R1 は−COCHX2 又は−COCX3 (Xは
ハロゲン原子を示す。)を示す。〕で表わされるβ−D
−グルコ−ス
What is claimed is: Claims 1 Wherein, R 1 is -COCHX 2 or -COCX 3 (X in. Which a halogen atom) shows a. ] -D represented by
-Glucose
JP32841391A 1991-11-18 1991-11-18 Beta-d-glucose Granted JPH0525192A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32841391A JPH0525192A (en) 1991-11-18 1991-11-18 Beta-d-glucose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32841391A JPH0525192A (en) 1991-11-18 1991-11-18 Beta-d-glucose

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP25948087A Division JPS63119494A (en) 1987-10-16 1987-10-16 Intermediate for etoposide

Publications (2)

Publication Number Publication Date
JPH0525192A true JPH0525192A (en) 1993-02-02
JPH0575759B2 JPH0575759B2 (en) 1993-10-21

Family

ID=18209988

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32841391A Granted JPH0525192A (en) 1991-11-18 1991-11-18 Beta-d-glucose

Country Status (1)

Country Link
JP (1) JPH0525192A (en)

Also Published As

Publication number Publication date
JPH0575759B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
JPH053476B2 (en)
JPS6328438B2 (en)
JPH0313239B2 (en)
JP2899577B2 (en) Method for selective isolation of 2 ', 2'-difluorocytidines
JPS6247196B2 (en)
JP3677790B2 (en) Nucleoside derivatives and process for producing the same
KR100953031B1 (en) Process for the preparation of ribavirin
JPH0525192A (en) Beta-d-glucose
JP3914279B2 (en) Method for producing d4T from 5-methyluridine
JPH09309896A (en) Glycosidation of colchicine derivative and its formed product
JPH0217199A (en) Production of 2'-deoxy-beta-adenosine
JPH06135988A (en) Nucleotide derivative
JP2547125B2 (en) 2 ', 3'-dideoxy-2', 3'-disubstituted-nucleosides and process for their production
JPS5998098A (en) Novel method for preparing 4'-demethyl- epipodophyllotoxin-beta-d-ethylidene glucoside and acyl derivative thereof
JPS63119494A (en) Intermediate for etoposide
JP2571059B2 (en) Method for producing 1,3,4-tri-O-acyl-2-deoxy-β-D-erythro-pentapyranose
JP3023804B2 (en) Method for producing 3'-deoxy-3'-fluorothymidine
JPH023799B2 (en)
JPH0363560B2 (en)
US20050159371A1 (en) Process for producing erythromycin a derivative
JPH032875B2 (en)
JPH1059919A (en) Production of asymmetric azine
JPH11130791A (en) Production of 2',5'-dideoxy-5'-azidonucleosides
JP2504934B2 (en) 1,6,7-Triacylforskolin derivative
JPH07252293A (en) Deoxyribonucleoside derivative and its production

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term